5PSQ-005 Analysis of anti-angiogenesis-related adverse events associated with vascular endothelial growth factor receptor-tyrosine kinase inhibitors (VEGFR-TKIs) in patients with metastatic renal cell carcinoma

Autor:	N Lee, JL Lee, JY Lee
Rok vydání:	2023
Zdroj:	Section 5: Patient safety and quality assurance.
DOI:	10.1136/ejhpharm-2023-eahp.233
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::231976c9fca115d241bb9a456dfe97fb https://doi.org/10.1136/ejhpharm-2023-eahp.233 Zobrazit plný text záznamu